Research & Analysis1h ago
European Stocks Fall on Novartis Trial Failures, Oil Price Surge
The STOXX 600 dropped 0.6 percent to 646.1 points as Novartis shares plunged 10.2 percent following failed drug trials and Brent crude climbed near $98.50 a barrel.